Zinc Patents (Class 424/641)
-
Publication number: 20140220155Abstract: A method of stimulating elastin and/or collagen production in the tissues of the vagina, comprising the steps of providing a composition including at least one of a water soluble zinc salt such as zinc sulfate and a peroxisome proliferator-activated receptor beta/delta (PPAR 13/8) agonist, and administering the composition to the tissue of the vagina. Compositions for stimulating 5 elastin and/or collagen production in the tissues of the vagina are also disclosed.Type: ApplicationFiled: July 10, 2012Publication date: August 7, 2014Applicant: UNIVERSITY OF MIAMIInventors: Peter Takacs, Keith A. Candiotti, Carlos A. Medina
-
Publication number: 20140220157Abstract: The present invention relates to ionic compositions for debriding a tissue, particularly in the sinonasal cavity. The ionic components of the composition can include potassium, calcium, rubidium, zinc, bromide, and magnesium in an isotonic solution. In other embodiments, the ionic components of the composition can include magnesium, bromide, sulfate, sodium, and chloride.Type: ApplicationFiled: April 9, 2014Publication date: August 7, 2014Applicant: RED OAX HOLDINGS, LLCInventor: Kevin Powers
-
Publication number: 20140220145Abstract: An improved method for stimulating electrical activity in an eye is provided. Provided is a technique for implanting small, nanometer-sized photoactive devices into an eye to improve electrical activity within an eye or mitigate degradation of electrical response in damaged eyes.Type: ApplicationFiled: April 9, 2014Publication date: August 7, 2014Applicant: The Regents of the University of Colorado, a Body CorporateInventors: Jeffrey Olson, Naresh Mandava
-
Publication number: 20140220156Abstract: The present invention relates to ionic compositions for promoting mucosal reciliation, particularly in the sinonasal cavity. The ionic components of the composition can include potassium, calcium, rubidium, zinc, bromide, and magnesium in an isotonic solution. In other embodiments, the ionic components of the composition can include magnesium, bromide, sulfate, sodium, and chloride.Type: ApplicationFiled: April 9, 2014Publication date: August 7, 2014Applicant: Red Oax Holdings, LLCInventor: Kevin Powers
-
Patent number: 8796476Abstract: Pest controlling compositions exhibiting enhanced pesticidal activity levels and methods for preparing the same are disclosed. In one embodiment, a method includes providing a liquid composition that includes at least one pesticide and at least one co-ingredient that enhances pesticidal activity of the composition compared to a composition dissimilar only in not having the at least one co-ingredient. The at least one co-ingredient may include at least one metal oxide, a combination of at least one transition metal salt and at least one proteinaceous material or a combination of at least one proteinaceous material and at least one polymeric material. The method further includes spray drying the liquid composition to provide a solid composition. In one aspect of this embodiment, the solid composition provided by the spray drying exhibits enhanced pesticidal activity compared to the liquid composition.Type: GrantFiled: April 27, 2010Date of Patent: August 5, 2014Assignee: Dow AgroSciences, LLCInventors: Stephen L. Wilson, Lei Liu, James D. Thomas, Raymond E. Boucher, Jr., James E. Dripps, Margaret S. Kempe, Martin C. Logan, Douglas J. Linscott, John M. Atkinson
-
Publication number: 20140212507Abstract: Disclosed is a method for determining a supplement regime for a subject diagnosed with age-related macular degeneration (AMD). The method involves determining the subject's risk of developing advanced AMD based on their genetic profile for the complement factor H gene and the ARMS2 gene and administering a supplement containing antioxidants and/or zinc based on their risk of developing advanced AMD.Type: ApplicationFiled: July 31, 2013Publication date: July 31, 2014Applicant: ArcticDx Inc.Inventors: Brent Zanke, Carl Awh
-
Patent number: 8790712Abstract: The present invention is drawn to a method of inducing thymocyte proliferation in a vertebrate animal with an impaired immune system comprising administering ?-aminolevulinic acid or a salt thereof every day in succession. The method further comprises administering at least one mineral.Type: GrantFiled: August 26, 2005Date of Patent: July 29, 2014Assignees: Cosmo Oil Co., Ltd., SBI Pharmaceuticals Co., Ltd.Inventors: Masao Kondo, Naomi Aiba, Setsuko Miyanari, Tohru Tanaka, Takaya Suzuki, Masahiro Ishizuka
-
Publication number: 20140205642Abstract: A method of preparing antimicrobial-containing polymeric products is provided, the method involving electrospinning a dispersion comprising a dispersible polymer, a fiberizing polymer, and one or more antimicrobial agents. The electrospun material is heated to remove solvent and the fiberizing polymer, giving a nonwoven polymeric material having antimicrobial agent incorporated therein. The material can be in the form of, for example, a non-woven sheet, tube, or covering.Type: ApplicationFiled: February 7, 2014Publication date: July 24, 2014Applicant: Zeus Industrial Products, Inc.Inventors: Robert L. Ballard, Bruce L. Anneaux, Joshua L. Manasco
-
Patent number: 8785194Abstract: The present invention provides a cell culture medium formulation that supports the in vitro cultivation, particularly in suspension, of mammalian cells, particularly epithelial cells and fibroblast cells, and methods for cultivating mammalian cells in suspension in vitro using these media. The media comprise a basal medium and a polyanionic or polyanionic compound, preferably a polysulfonated or polysulfated compound, and more preferably dextran sulfate. The present invention also provides chemically defined, protein-free eukaryotic cell culture media comprising an iron chelate and zinc, which is capable of supporting the growth (and particularly the high-density growth of mammalian cells) in suspension culture, increasing the level of expression of recombinant protein in cultured cells, and/or increasing virus production in cultured cells.Type: GrantFiled: May 8, 2009Date of Patent: July 22, 2014Assignee: Life Technologies CorporationInventors: Stephen Gorfien, Richard Fike, Glenn Godwin, Joyce Dzimian, David A. Epstein, Dale Gruber, Don McClure, Paul Price
-
Publication number: 20140200138Abstract: The present invention provides a composition comprising an acidified aqueous solution of (1) micro colloidal silicic acid, (2) boric acid, and (3) a water absorbing additive, having a pH value of equal to or less than 1, wherein the micro colloidal silicic acid has particle sizes in the range of 1-8 nm, especially in the range of 1.5-6 nm. The invention also provides a particulate product obtainable by the method according to claim 18, wherein the particles comprise (1) silicic acid, (2) boric acid, and (3) the water absorbing additive, and wherein at least 90% of the particles in the particulate product have particle sizes in the range of 0.3-5 ?m.Type: ApplicationFiled: December 13, 2013Publication date: July 17, 2014Applicant: Barlaa B.V.Inventors: Henk Maarten LAANE, Walter Ferdinand WITTERLAND
-
Patent number: 8778410Abstract: The present invention provides an oral or enteral composition incorporating not only BCAA but other nutrients to be conducive to comprehensive recovery from fatigue, and improvement in total physical condition. The oral or enteral composition is formulated as a composite of a branched-chain amino acid, coenzyme Q10, L-carnitine, a citric acid, and zinc.Type: GrantFiled: February 19, 2009Date of Patent: July 15, 2014Assignees: Earnest Medicine Co., Ltd., Otsuka Pharmaceutical Factory, Inc.Inventors: Takashi Higashiguchi, Takako Hatakeyama
-
Patent number: 8778409Abstract: A composition, system and method for modifying an olfactory response to an odorant is disclosed. In some embodiments, the composition includes crystalline metal nanoparticles dispersed in an aqueous medium. The composition is applied to olfactory tissues using a suitable applicator or dispenser. The metal nanoparticles are believed to interact with a G-protein coupled to receptor located in the cilia to moderate (enhance or reduce) sensitivity or ability to smell particular odorants. In accordance with an embodiment of the invention, the composition includes one or more odorants.Type: GrantFiled: September 21, 2012Date of Patent: July 15, 2014Assignee: Auburn UniversityInventors: Vitaly J. Vodyanoy, Lewis G. Scharpf, Alexandre Samoylov, Nilmini Viswaprakash, Ludmila Petrovna Globa, Edward E. Morrison
-
Patent number: 8772334Abstract: A broad spectrum antimicrobial composition consisting essentially of an iodopropynyl compound in combination with a benzimidazole and a metal borate is disclosed. The composition can be used to protect industrial systems against microbial growth and, more particularly, to protect substrates such as paints, coatings, stucco, concrete, stone, cementaceous surfaces, wood, wood-plastic composites, caulking, sealants, textiles, leather, wood, preservatives, metal working fluids, drilling muds, clay slurries, glazes, optical brighteners, carpet backing, and pigments against microbial growth. The composition can be used as a preservative for aqueous products.Type: GrantFiled: July 18, 2011Date of Patent: July 8, 2014Inventors: Kamlesh Gaglani, Maihua Yang
-
Patent number: 8765163Abstract: The present invention relates to a biocompatible ceramic material comprising Sr, Mg or Ba doped Hardystonite (Ca2ZnSi2O7), and a method for its synthetic preparation. The present invention also relates to an implantable medical device comprising biocompatible doped Hardystonite, and a method for its production. The present invention further relates to a method for improving the long term stability of an implantable medical device and an implantable drug delivery device comprising doped Hardystonite. Further, the present invention relates to the use of comprising biocompatible doped Hardystonite in the regeneration or resurfacing of tissue.Type: GrantFiled: July 10, 2009Date of Patent: July 1, 2014Assignee: The University of SydneyInventors: Hala Zreiqat, Chengtie Wu, Colin Dunstan
-
Patent number: 8758835Abstract: It is described a composition comprising as active ingredients green tea extract and pomegranate extract for the prevention or reduction of the progression of prostate cancer.Type: GrantFiled: July 24, 2009Date of Patent: June 24, 2014Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.Inventors: Franco Gaetani, Ashraf Virmani
-
Patent number: 8753561Abstract: Methods for processing substrate surfaces comprising metallic nanoparticles are disclosed. The methods involve providing a substrate surface comprising metallic nanoparticles, and exposing the substrate surface to a plasma.Type: GrantFiled: June 20, 2008Date of Patent: June 17, 2014Assignees: Baxter International Inc., Baxter Healthcare SAInventors: Yann-Per Lee, John-Bruce D. Green, Jeffrey Bloss, Ozlem Yardimci
-
Publication number: 20140161906Abstract: The present application describes therapy with angiogenesis antagonists such as anti-VEGF antibodies. In particular, the application describes the use of such angiogenesis antagonists to treat end-stage liver disease and end-stage liver disease complications. The present application also describes the use of such angiogenesis antagonists to treat disorders of altered venous proliferation such hemorrhoids and varicose veins.Type: ApplicationFiled: June 12, 2013Publication date: June 12, 2014Applicant: UNIVERSITY OF UTAH RESEARCH FOUNDATIONInventors: Jason Schwartz, Thomas P. Kennedy
-
Publication number: 20140161851Abstract: Cosmetic or dermatological compositions and substrates, containing a NIR light-emitting material, and methods for stimulating healing and/or regenerative properties in the skin, hair and/or scalp are provided.Type: ApplicationFiled: December 3, 2013Publication date: June 12, 2014Applicant: ELC Management LLCInventor: William Robert Bickford
-
Publication number: 20140161850Abstract: Cosmetic or dermatological compositions and substrates, containing a NIR light-emitting material, and methods for stimulating healing and/or regenerative properties in the skin, hair and/or scalp are provided.Type: ApplicationFiled: December 3, 2013Publication date: June 12, 2014Applicant: ELC Management LLCInventor: William Robert Bickford
-
Publication number: 20140161907Abstract: The present invention relates to compositions that may be swallowable, chewable or dissolvable, comprising various vitamins and minerals, and in a specific embodiment comprising vitamin A, beta carotene, B-complex vitamins, vitamin C, vitamin D3, vitamin E, iron, magnesium and zinc, and methods for using these compositions for nutritional supplementation in subjects undergoing physiologically stressful events, such as, for example and without limitation, pregnancy, lactation or any disease state.Type: ApplicationFiled: February 18, 2014Publication date: June 12, 2014Inventors: John A. Giordano, Charles J. Balzer
-
Publication number: 20140161849Abstract: Cosmetic or dermatological compositions and substrates, containing a NIR light-emitting material, and methods for stimulating healing and/or regenerative properties in the skin, hair and/or scalp are provided.Type: ApplicationFiled: December 3, 2013Publication date: June 12, 2014Applicant: ELC Management LLCInventor: William Robert Bickford
-
Publication number: 20140154292Abstract: Articles have a glass layer on a substrate. The glass layer has antimicrobial properties via a metal or metal alloy. The glass layer is made using a doped glass frit which may be deposited by screen printing. The CTE of the glass layer and the substrate can be matched.Type: ApplicationFiled: November 21, 2013Publication date: June 5, 2014Applicant: CORNING INCORPORATEDInventors: Nicholas Francis Borrelli, Melinda Ann Drake, Robert Michael Morena
-
ANTIMICROBIAL AGENTS AND METHODS FOR USE THEREOF IN THE ABATEMENT OF FOOD BORNE PATHOGENIC ORGANISMS
Publication number: 20140154337Abstract: Antimicrobial agents and methods for the abatement of food borne pathogenic organisms—particularly, Escherichia coli—include the steps of providing a specifically formulated humic composition and, thereafter, applying the humic composition as an antimicrobial agent for the abatement of Escherichia coli. In at least some applications of the present invention, other substances are introduced in combination with the humic composition thereby synergistically providing in certain applications a greater effect than otherwise independently obtainable.Type: ApplicationFiled: February 5, 2014Publication date: June 5, 2014Inventor: Lynn C. Wilford -
Publication number: 20140147514Abstract: A process for extracting vitamins and minerals from a first plant matter(s) is disclosed wherein the said first plant matter(s) is treated with acidic matter followed by extraction with water. Said treatment converts the water-insoluble vitamins and minerals into water-soluble forms leading to a more comprehensive extraction with better yields of the plant constituents. Suitable selection of the first and second plant matter(s) and their proportions yields an extract that is a ready-made formulation of the desired vitamins and minerals in RDA quantities. Other advantages are reduced processing times and processing steps. Extraction of guava fruits, guava leaves, holy basil leaves, lemon peels, amla fruits, annato seeds, Wrightia tinctoria, Lantana camara, bamboo shoots, mustard seeds, and curry leaves is described.Type: ApplicationFiled: July 30, 2012Publication date: May 29, 2014Inventors: Ramaswamy Rajendran, Kamala Rajendran
-
Patent number: 8729135Abstract: This invention relates to a stabilized aqueous glutaraldehyde solution including 0.005% to 45% m/v, suitably 10% to 45% m/v solution of glutaraldehyde, an alcohol ethoxylate non-ionic surfactant, a buffer and a sufficient amount of a pH modifier to bring the pH of the solution to 6.0 to 8.5. The glutaraldehyde and the alcohol ethoxylate non-ionic surfactant are chemically bound together, suitably by complexing. These stable solutions can be stored for a period of at least six months without the glutaraldehyde polymerizing or the pH dropping below 5.0.Type: GrantFiled: March 13, 2009Date of Patent: May 20, 2014Inventor: Antonietta Pamela Martin
-
Patent number: 8728535Abstract: In one embodiment of the present invention, a pharmaceutically-acceptable single-dosage formulation consists essentially of about 500 mg of vitamin C; about 400 IUs of vitamin D3; about 125 IUs of vitamin E; about 25 mg of vitamin B1; about 3.4 mg of vitamin B2; about 35 mg of niacin; about 35 mg of vitamin B6; about 1.25 mg of folic acid; about 70 mcg of vitamin B12; about 5 mg of pantothenic acid; about 75 mcg of biotin; about 35 mg of magnesium; about 35 mg of zinc; about 1 mg of copper; about 125 mcg of selenium; about 150 mcg of chromium; about 10 mg of alpha lipoic acid; about 35 mg of co-enzyme Q-10; about 400 mcg of lutein; about 125 mcg of lycopene; and at least one or more excipients.Type: GrantFiled: June 19, 2012Date of Patent: May 20, 2014Assignee: Vertical Pharmaceuticals, LLCInventors: Steven A. Squashic, Kevin M. Hudy, David C. Purdy
-
Publication number: 20140134273Abstract: The present invention relates to ionic compositions for enhancing wound healing, particularly in the sinonasal cavity. The ionic components of the composition can include potassium, calcium, rubidium, zinc, bromide, and magnesium in an isotonic solution. In other embodiments, the ionic components of the composition can include magnesium, bromide, sulfate, sodium, and chloride. Methods of enhancing wound healing, enhancing sinonasal mucosal healing, promoting mucosal reciliation, and debriding tissue by administering the compositions of the present invention are also presented.Type: ApplicationFiled: January 23, 2014Publication date: May 15, 2014Applicant: Red Oax Holdings, LLCInventor: Kevin Powers
-
Publication number: 20140134272Abstract: The present invention relates to ionic compositions for enhancing wound healing, particularly in the sinonasal cavity. The ionic components of the composition can include potassium, calcium, rubidium, zinc, bromide, and magnesium in an isotonic solution. In other embodiments, the ionic components of the composition can include magnesium, bromide, sulfate, sodium, and chloride. Methods of enhancing wound healing, enhancing sinonasal mucosal healing, promoting mucosal reciliation, and debriding tissue by administering the compositions of the present invention are also presented.Type: ApplicationFiled: January 23, 2014Publication date: May 15, 2014Applicant: Red Oax Holdings, LLCInventor: Kevin Powers
-
Publication number: 20140127179Abstract: A formulation of supplement is able to boost the natural cells, both increasing the population of the natural cells and enhancing the natural cell's activity. The formulation can be administered via different forms, such as tablet, injection, skin absorption and etc. This formulation comprises 16 different components, including Alpha Lipoic Acid, Arabinoxylin, Curcumin, Garlic, Genistein, Ginseng, Lentinan, Mistletoe, N-Acetylcysteine, Resveratrol, Selenium, Vitamin B Complex, Vitamin C, Vitamin D3, Vitamin E and Zinc. By virtue of enhancing the natural killer cells (NKC) in the body, the formation is helpful for the prevention and treatment of a number of different human or animal diseases, such as cancers and viral infections. In addition, certain synergistic effects have been observed between different components in the formulation, which further enhances the beneficial effect of the formulation.Type: ApplicationFiled: November 4, 2013Publication date: May 8, 2014Applicant: SCIENTIFIC FORMULATIONS, LLCInventor: Jerry Thomas THORNTHWAITE
-
Publication number: 20140127320Abstract: A composition and method adapted for delivery of hydrophilic, biologically-active agents are disclosed. The composition can include a reverse microemulsion formed from at least one hydrophilic, biologically-active agent solubilized by a hydrophobic reverse emulsion surfactant in a non-stinging, volatile, hydrophobic solvent. The non-stinging, volatile, hydrophobic solvent is selected from the group consisting of volatile linear and cyclic siloxanes, volatile linear, branched, and cyclic alkanes, volatile fluorocarbons and chlorofluorocarbons, liquid carbon dioxide under pressure, and combinations thereof. The reverse microemulsion can be an optically clear solution.Type: ApplicationFiled: October 21, 2013Publication date: May 8, 2014Applicant: ROCHAL INDUSTRIES, LLPInventors: Joseph Charles Salamone, Xiaoyu Chen, Ann Beal Salamone, Katelyn Elizabeth Reilly
-
Publication number: 20140113004Abstract: Methods of inhibiting Barrett's esophagus and/or adenocarcinoma in a subject are provided. In a particular embodiment, the method comprises administering at least one composition comprising at least one zinc compound and at least one pharmaceutically acceptable carrier to the esophagus of the subject. The zinc may be a pharmaceutically acceptable salt of zinc, such as zinc gluconate. The zinc may be administered, for example, orally, topically, or by an implantable medical device. In a particular embodiment, the methods further comprise administering at least one analgesic, anesthetic, or other therapeutic agent or therapy for the treatment of Barrett's esophagus. The method may further comprise monitoring the progression of Barrett's esophagus in the subject.Type: ApplicationFiled: May 7, 2012Publication date: April 24, 2014Applicants: Monk Street Partners LLC, Lankenau Institute for Medical ResearchInventors: James M. Mullin, Jonathan Raines
-
Patent number: 8703174Abstract: A pet supplement includes a joint preserving and joint rebuilding composition comprising chicken collagen type II, glucosamine hydrochloride and chondroitin sulfate, a vitamin composition comprising vitamins C, D and K, a mineral composition comprising calcium, magnesium, zinc, copper, manganese and boron, a herbal anti-oxidant cofactor blend comprising citrus bioflavonoids, red grapes anthocyanins, turmeric rhizome, boswellia resin and fennel seed. Each of these ingredients is intimately mixed into the pet supplement and orally delivered to the pet in the form of a segment, paste or powder having a size and weight or other dosage measuring feature adjusted in accordance with the pet's weight. A synergistic action between these ingredients preserves and rebuilds the pet's joints, and is nutritionally beneficial for the pet.Type: GrantFiled: September 15, 2006Date of Patent: April 22, 2014Assignee: I did It IncInventor: Marni Markell Hurwitz
-
Patent number: 8703166Abstract: Antimicrobial and algaecidal products are disclosed. In general, the antimicrobial or algaecidal products can be adhered to structural components of buildings and include particles that, when combined with water, produce a solution that is toxic to organisms such as algae. The products provide an algaecidal wash as water percolates on, or through the product, and can prevent or control growth of unsightly algae and other microbes.Type: GrantFiled: January 20, 2011Date of Patent: April 22, 2014Inventor: John Flynn
-
Publication number: 20140106002Abstract: A homeopathic composition and method for treating a variety of skin irritations, wounds, and diseases is disclosed. The homeopathic composition may contain as active ingredients salicyclic acid, trona or one of its salts, and at least one homeopathic agent.Type: ApplicationFiled: March 15, 2013Publication date: April 17, 2014Inventors: Ned L. Jensen, Peter E. Fuller
-
Publication number: 20140105940Abstract: The present invention relates to a biocompatible material and in particular to a two-phase or composite biocompatible ceramic material, wherein the first phase is a doped calcium zinc silicate and the second phase is a metal oxide. In an embodiment, the invention has been developed for use in tissue regeneration including bone tissue. In other embodiments, the invention has been developed as a coating to improve the long-term stability of prior art implantable medical devices.Type: ApplicationFiled: June 1, 2012Publication date: April 17, 2014Applicant: The University of SydneyInventors: Hala Zreiqat, Seyed-Iman Roohani-Esfahani, Colin Dunstan, Jiao Jiao Li
-
Publication number: 20140099348Abstract: Provided is a photocatalytic composition comprising zinc (Zn) doped titanium dioxide (TiO2) nanoparticles, wherein the ratio of titanium dioxide nanoparticles to zinc is from about 5 to about 150. The photocatalytic composition absorbs electromagnetic radiation in a wavelength range from about 200 nm to about 500 nm, and the absorbance of light of wavelengths longer than about 450 nm is less than 50% the absorbance of light of wavelengths shorter than about 350 nm. Further provided is a method for treating or preventing microbial diseases and infestations in a plant and a method for increasing crop yield of a plant by applying the photocatalytic compositions taught herein to the surface of a plant. Also provided is a method for treating microbial diseases on a surface by applying the photocatalytic compositions taught herein to a surface illuminated by artificial light.Type: ApplicationFiled: November 1, 2013Publication date: April 10, 2014Inventors: Stewart Benson Averett, Devron R. Averett
-
Publication number: 20140099350Abstract: The present invention relates to micro-sized particles having anti-biocontaminant properties. Each particle is comprised of a central metal core, or support structure, (for example, alumina oxide) and has on its surface, one or more anti-biocontaminant metals and at least one redox agent.Type: ApplicationFiled: March 26, 2013Publication date: April 10, 2014Inventor: Dynamic Adsorbents, Inc.
-
Patent number: 8691726Abstract: A synergistic antimicrobial composition containing a glyphosate compound and zinc pyrithione is provided. Also provided is a method of inhibiting the growth of or controlling the growth of microorganisms in a building material by adding such a synergistic antimicrobial composition. Also provided is a coating composition containing such a synergistic antimicrobial composition, and a dry film made from such a coating composition.Type: GrantFiled: December 9, 2011Date of Patent: April 8, 2014Assignee: Dow Global Technologies LLCInventors: Emerentiana Sianawati, Sudhakar Balijepalli
-
Patent number: 8691285Abstract: Methods of using a non-irritant, low pH acidic composition to destroy undesirable microorganisms are described. The methods may be used on food products, food processing equipment, and in aqueous solutions.Type: GrantFiled: July 14, 2011Date of Patent: April 8, 2014Assignee: CMS Innovative Technologies, Inc.Inventors: Barry Cummins, David Creasey
-
Patent number: 8691725Abstract: A synergistic antimicrobial composition containing a glyphosate compound and thiabendazole is provided. Also provided is a method of inhibiting the growth of or controlling the growth of microorganisms in a building material by adding such a synergistic antimicrobial composition. Also provided is a coating composition containing such a synergistic antimicrobial composition, and a dry film made from such a coating composition.Type: GrantFiled: December 9, 2011Date of Patent: April 8, 2014Assignee: Dow Global Technologies LLCInventors: Emerentiana Sianawati, Sudhakar Balijepalli
-
Patent number: 8686216Abstract: The present invention relates to a water-absorbing particulate composition comprising water-absorbing polymer particulate structure comprising partly neutralized, crosslinked polyacrylate, a surface crosslinking agent and a compound of the structure I in which R1, R2, R3 and R4 can be identical or different and in each case represent a hydrogen atom, a halogen atom, a C1- to C4-hydrocarbon group or a hydroxyl group, R5 represents a hydrogen atom, a C1- to C4-hydrocarbon group or an acetyl group, n represents an integer chosen from the group consisting of 1, 2 or 3 and Mn+ represents an n-valent metal cation or an H+ cation. In addition, the present invention also relates to a process for the preparation of a water-absorbing composition, the water-absorbing composition obtainable by this process, a composite, a process for the production of a composite, the composite obtainable by this process, and products, such as hygiene articles.Type: GrantFiled: February 27, 2009Date of Patent: April 1, 2014Assignee: Evonik Degussa GmbHInventors: Laurent Wattebled, Franck Furno
-
Patent number: 8679468Abstract: The present invention provides a deoxidizing multilayered body, which sufficiently suppresses the production of odorous organic components produced with oxidation, and which absorbs oxygen at a fast rate. The present invention is the deoxidizing multilayered body that is constituted by laminating at least an isolation layer (A) that contains a thermoplastic resin, an odor absorption layer (B), which is made from an odor absorbent resin composition (b) that contains an oxidizable thermoplastic resin, a transition metal catalyst, and an odor absorbent, an oxygen absorption layer (C), which is made from an oxygen absorbent resin composition (c) that contains an oxidizable thermoplastic resin and a transition metal catalyst, and an oxygen barrier layer (D), which contains an oxygen barrier substance, in this order.Type: GrantFiled: August 26, 2009Date of Patent: March 25, 2014Assignee: Mitsubishi Gas Chemical Company, Inc.Inventors: Kimitaka Nakao, Emiko Yokose
-
Publication number: 20140079807Abstract: The disclosure is directed to glass compositions that incorporate copper into an otherwise homogeneous glass and to a method for making such glass. This incorporation of the copper into the glass composition imparts significant antimicrobial activity to the glass. A method of making a copper-containing glass article comprises: batching a glass batch comprising: 40-85 SiO2; 10-40 B2O3; 1-19 Al2O3; 0.1-20 CuO or a selected salt of Cu that is convertible into CuO during melting; 0-20 M2O, wherein M is Li, Na, K, or combinations thereof; 0-25 RO, wherein R is Ca, Sr, Mg, or combinations thereof; and 0-20 ZnO. melting the batch to form a melted glass; and forming the melted glass to form the copper-containing glass article having antimicrobial properties.Type: ApplicationFiled: March 27, 2012Publication date: March 20, 2014Inventors: Nicholas Francis Borrelli, Odessa Natalie Petzold, Joseph Francis Schroeder, Thomas Philip Seward, Florence Verrier, Ying Wei
-
Publication number: 20140079809Abstract: The use of L-carnitine, in combination with antioxidants such as vitamin E and inorganic elements such as manganese, zinc, sodium and potassium, for the preparation of a physiological supplement or medicament for ophthalmic use, for the prevention or treatment of accomodative asthenopia is disclosed.Type: ApplicationFiled: November 18, 2013Publication date: March 20, 2014Applicant: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.Inventors: Nicola PESCOSOLIDO, Aleardo KOVERECH
-
Publication number: 20140079810Abstract: Embodiments disclosed herein relate to improved X-ray contrast media compositions and methods of using the same for treating symptoms related to allergic reactions, inflammatory conditions, symptoms of the common cold and certain cancers.Type: ApplicationFiled: May 6, 2013Publication date: March 20, 2014Inventor: Elliott C. Lasser
-
Publication number: 20140079811Abstract: Embodiments disclosed herein relate to improved X-ray contrast media compositions and methods of using the same for treating symptoms related to allergic reactions, inflammatory conditions, symptoms of the common cold and certain cancers.Type: ApplicationFiled: May 7, 2013Publication date: March 20, 2014Inventor: Elliott C. Lasser
-
Patent number: 8673367Abstract: A new composite comprises (a) 10.1-99.9% by weight of elemental Ag and (b) 0.1-89.9% by weight of ZnO, wherein the sum of (a) and (b) makes 90% or more by weight of the composite and wherein the elemental Ag has a primary particle size of 10-200 nm and/or the ZnO has a primary particle size of 0.1 to below 50 ?m and/or the composite has a particle size distribution of 0.1-50 ?m and/or a BET surface area of 10-100 m2/g. The novel composite may be obtained by the steps (i) mixing a first mixture of at least one Ag-salt with a second mixture of at least one Zn-salt thereby forming a third mixture of Ag- and Zn-salts, (ii) adding the third mixture to a mixture of a carbonate source, (iii) co-precipitating of the Ag- and Zn-carbonates formed in step (ii), (iv) washing of the Ag- and Zn-carbonates and (v) thermal decompositing of the Ag- and Zn-carbonates.Type: GrantFiled: August 16, 2010Date of Patent: March 18, 2014Assignee: Polymers CRC Ltd.Inventors: Thomas Weiβ, Rainer Xalter
-
Publication number: 20140056994Abstract: The invention relates to a fixed-dose association of phytate and zinc in synergic proportions for use in the treatment of crystallization of hydroxyapatite. Advantageously, said association is in a molar ratio between the phytate and the zinc exceeding 4:1. The invention also relates to the use of said association for manufacturing a drug for the treatment, prophylaxis and/or prevention crystallization of hydroxyapatite in humans.Type: ApplicationFiled: February 19, 2013Publication date: February 27, 2014Applicant: Universitat De Les Illes BalearsInventor: Universitat De Les Illes Balears
-
Publication number: 20140056948Abstract: A hard tissue regeneration material and a method for manufacturing the same are disclosed. The hard tissue regeneration material of the present invention comprises: ZnO particles selected from the group consisting of crystallized ZnO particles, crystallized ZnO nanorods, nano-ZnO hollow fibers, and a combination thereof; and at least one selected from the group consisting of polycarboxylate cement, glass ionomer cements, and collagen.Type: ApplicationFiled: February 21, 2013Publication date: February 27, 2014Applicant: NATIONAL CHENG KUNG UNIVERSITYInventor: National Cheng Kung University
-
Patent number: 8647679Abstract: Disclosed herein are core-shell type zinc oxide microparticles, a dispersion containing such microparticles, and a production process and uses of the microparticles and the dispersion. As disclosed herein, the core-shell type zinc oxide microparticles have an average particle diameter of from 50 to 1,000 nm. The core is a secondary particle of spherical shape to the surface of which a polymer is attached as a shell. Methods for making the microparticles include the steps of: mixing together a zinc salt and a polymer in an organic solvent so as to obtain a mixture; and heating/refluxing the mixture at a predetermined temperature so as to cause core-shell type zinc oxide microparticles to precipitate, wherein the zinc salt is zinc acetate; and uses such as cosmetics, resins and fibers which contain the core-shell type zinc oxide microparticles and have an ultraviolet light blocking action.Type: GrantFiled: February 6, 2009Date of Patent: February 11, 2014Assignee: National Institute of Advanced Industrial Science and TechnologyInventors: Noriya Izu, Ichiro Matsubara, Toshio Itoh, Woosuck Shin, Maiko Nishibori